Diet, exercise & lifestyle × glycemic control

Observational studyPloS one2026

GLIMSI: A real-world, multicenter study assessing the effectiveness and safety of Sitagliptin + Glimepiride + Metformin FDC in Indian patients with Type 2 diabetes.

Kunal Zaveri et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedas reported · 1,235 people · 2026

No range given

Reported lower glycemic control, no range given

−0.77percentage points

As reported

difference −0.77 %, no interval

One number in the abstract

the abstract, start to end

decreased from 8.20 ± 0.60% to 7.08 ± 0.77% (p < 0.0001), fasting blood

← favours treatmentfavours comparator →
could be chance
No interval given · direction only, strength unknown
Glycemic control
−0.77
Diet, exercise & lifestyleGlycemic control
1 / 3

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41650186